Metraipolis › archive › dc_df97af68ef74

Repurposed Drugs for Heterotopic Ossification Management: Revitalizing Therapeutic Strategies — Europe PMC PMID:41304856

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41304856
DOI
10.3390/ph18111609
License (as archived)
solo-consultazione
Archived
2026-11-09T01:42:04.872Z
SHA-256 of the archived text
77c76644f540aa3abf1de9af6357fb3bd05c021d4753568325be6ef0c020cb29
Stable URL of this page
https://metraipolis.com/documento/dc_df97af68ef74

How to cite

Repurposed Drugs for Heterotopic Ossification Management: Revitalizing Therapeutic Strategies — Europe PMC PMID:41304856 — Europe PMC (en), https://europepmc.org/article/MED/41304856 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_df97af68ef74 (Metraipolis archive dc_df97af68ef74, sha256 77c76644f540aa3abf1de9af6357fb3bd05c021d4753568325be6ef0c020cb29)
BibTeX
@misc{dcdf97af68ef74,
  title = {Repurposed Drugs for Heterotopic Ossification Management: Revitalizing Therapeutic Strategies — Europe PMC PMID:41304856},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41304856},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_df97af68ef74; sha256 77c76644f540aa3abf1de9af6357fb3bd05c021d4753568325be6ef0c020cb29},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41304856. Agents can read the archived copy with the MCP tool read_document.